1. Home
  2. SYNA vs AAPG Comparison

SYNA vs AAPG Comparison

Compare SYNA & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYNA
  • AAPG
  • Stock Information
  • Founded
  • SYNA 1986
  • AAPG 2009
  • Country
  • SYNA United States
  • AAPG China
  • Employees
  • SYNA N/A
  • AAPG N/A
  • Industry
  • SYNA Computer peripheral equipment
  • AAPG Biotechnology: Pharmaceutical Preparations
  • Sector
  • SYNA Technology
  • AAPG Health Care
  • Exchange
  • SYNA Nasdaq
  • AAPG Nasdaq
  • Market Cap
  • SYNA 2.0B
  • AAPG 1.7B
  • IPO Year
  • SYNA 2002
  • AAPG 2025
  • Fundamental
  • Price
  • SYNA $49.07
  • AAPG $18.72
  • Analyst Decision
  • SYNA Buy
  • AAPG Buy
  • Analyst Count
  • SYNA 10
  • AAPG 1
  • Target Price
  • SYNA $96.67
  • AAPG N/A
  • AVG Volume (30 Days)
  • SYNA 687.7K
  • AAPG 51.6K
  • Earning Date
  • SYNA 05-08-2025
  • AAPG 05-06-2025
  • Dividend Yield
  • SYNA N/A
  • AAPG N/A
  • EPS Growth
  • SYNA N/A
  • AAPG N/A
  • EPS
  • SYNA 4.20
  • AAPG N/A
  • Revenue
  • SYNA $1,009,600,000.00
  • AAPG $134,352,180.00
  • Revenue This Year
  • SYNA $13.20
  • AAPG N/A
  • Revenue Next Year
  • SYNA $10.04
  • AAPG $386.68
  • P/E Ratio
  • SYNA $11.67
  • AAPG N/A
  • Revenue Growth
  • SYNA N/A
  • AAPG 341.77
  • 52 Week Low
  • SYNA $41.80
  • AAPG $16.50
  • 52 Week High
  • SYNA $98.00
  • AAPG $24.02
  • Technical
  • Relative Strength Index (RSI)
  • SYNA 37.81
  • AAPG N/A
  • Support Level
  • SYNA $46.37
  • AAPG N/A
  • Resistance Level
  • SYNA $50.88
  • AAPG N/A
  • Average True Range (ATR)
  • SYNA 4.23
  • AAPG 0.00
  • MACD
  • SYNA -0.17
  • AAPG 0.00
  • Stochastic Oscillator
  • SYNA 31.89
  • AAPG 0.00

About SYNA Synaptics Incorporated $0.001 Par Value

Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. Geographically, it derives a majority of revenue from China. The company operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: